GlaxoSmithKline | GSK - Market Capitalization


GlaxoSmithKline reported GBP77.3B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 444.6B 59.91B Jun/2026
Alcon AG USD 33.76B 3.29B Jun/2026
Almirall EUR 2.76B 472.53M Dec/2025
Amgen USD 195.44B 5.55B Jun/2026
argenx SE USD 57.63B 13.25B Jun/2026
AstraZeneca USD 289.99B 11.26B Jun/2026
Bayer EUR 47.56B 8.87B Jun/2026
Biogen USD 31.9B 5B Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Eli Lilly USD 1.13T 260.54B Jun/2026
Fresenius EUR 22.51B 2.45B Jun/2026
Fresenius Medical Care EUR 10.55B 766.96M Jun/2026
Genmab DKK 17.1B 88.06B Jun/2026
Gilead Sciences USD 156.86B 16.13B Jun/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Glaxosmithkline GBP 109.29B 9.36B Mar/2026
GRIFOLS EUR 5.41B 181.49M Jun/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Lakefront Biotherapeutics EUR 1.73B 2.64M Jun/2026
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 18.98B 27.8B Jun/2026
Merck USD 317.37B 20.27B Jun/2026
Novartis USD 240.59B 67.17B Jun/2026
Novo Nordisk A/S DKK 1.4T 373.76B Jun/2026
Orion EUR 10.15B 316M Jun/2026
Pfizer USD 138.44B 15.37B Jun/2026
Philips EUR 23.09B 615.44M Jun/2026
Recordati EUR 10.44B 184.5M Jun/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
Smith & Nephew USD 12.7B 621.83M Jun/2026
UCB EUR 46.41B 13.94B Dec/2025